Great West Life Assurance CO Dexcom Inc Transaction History

Great West Life Assurance CO

$57.4 Billion
Q3 2024

A detailed history of Great West Life Assurance CO transactions in Dexcom Inc stock. As of the latest transaction made, Great West Life Assurance CO holds 370,136 shares of DXCM stock, worth $28.2 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

370,136

Previous 359,463 2.97%

Holding current value

$28.2 Million

Previous $40.8 Million 39.06%

% of portfolio

0.04%

Previous 0.08%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$64.0 - $116.06 $683,072 - $1.24 Million	10,673 Added 2.97%	370,136 $24.8 Million
Q2 2024 Aug 12, 2024	BUY	$110.31 - $140.45 $6.73 Million - $8.57 Million	61,050 Added 20.46%	359,463 $40.8 Million
Q1 2024 May 13, 2024	BUY	$114.22 - $140.1 $1.1 Million - $1.35 Million	9,662 Added 3.35%	298,413 $41.4 Million
Q4 2023 Feb 13, 2024	BUY	$75.49 - $124.16 $56,391 - $92,747	747 Added 0.26%	288,751 $35.7 Million
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $577,462 - $925,510	-6,710 Reduced 2.28%	288,004 $26.9 Million
Q2 2023 Aug 10, 2023	BUY	$112.47 - $130.98 $2.49 Million - $2.9 Million	22,150 Added 8.13%	294,714 $38.1 Million
Q1 2023 May 12, 2023	BUY	$104.0 - $122.92 $267,904 - $316,641	2,576 Added 0.95%	272,564 $31.7 Million
Q4 2022 Feb 10, 2023	SELL	$84.98 - $122.67 $289,356 - $417,691	-3,405 Reduced 1.25%	269,988 $30.7 Million
Q3 2022 Nov 01, 2022	SELL	$76.35 - $94.18 $96,277 - $118,760	-1,261 Reduced 0.46%	273,393 $22 Million
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $18.7 Million - $36.5 Million	274,654 New	274,654 $20.5 Million
Q2 2022 Aug 09, 2022	SELL	$67.99 - $132.89 $4.7 Million - $9.2 Million	-69,199 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$94.08 - $130.2 $27,189 - $37,627	-289 Reduced 0.42%	69,199 $37.3 Million
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $1,298 - $1,628	-10 Reduced 0.01%	69,488 $37.2 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $213,313 - $286,216	-1,999 Reduced 2.8%	69,498 $38.2 Million
Q2 2021 Aug 11, 2021	SELL	$80.99 - $107.93 $36,121 - $48,136	-446 Reduced 0.62%	71,497 $30.5 Million
Q1 2021 May 17, 2021	BUY	$84.79 - $104.74 $105,563 - $130,401	1,245 Added 1.76%	71,943 $25.7 Million
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $643,422 - $862,020	8,249 Added 13.21%	70,698 $26.1 Million
Q3 2020 Nov 17, 2020	SELL	$95.51 - $112.95 $57.7 Million - $68.2 Million	-603,819 Reduced 90.63%	62,449 $6.44 Million
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $57.8 Million - $68.4 Million	605,196 Added 990.95%	666,268 $68.7 Million
Q2 2020 Aug 17, 2020	BUY	$62.68 - $105.34 $730,472 - $1.23 Million	11,654 Added 23.58%	61,072 $24.7 Million
Q1 2020 May 14, 2020	SELL	$47.79 - $75.63 $101,267 - $160,259	-2,119 Reduced 4.11%	49,418 $13.4 Million
Q4 2019 Feb 11, 2020	SELL	$36.62 - $57.29 $165,339 - $258,664	-4,515 Reduced 8.06%	51,537 $2.82 Million
Q3 2019 Oct 25, 2019	BUY	$35.53 - $43.8 $36,631 - $45,157	1,031 Added 1.87%	56,052 $8.37 Million
Q2 2019 Jul 31, 2019	BUY	$27.84 - $38.92 $234,301 - $327,550	8,416 Added 18.06%	55,021 $0
Q1 2019 May 08, 2019	BUY	$28.07 - $38.18 $625,961 - $851,414	22,300 Added 91.75%	46,605 $5.54 Million
Q4 2018 Feb 12, 2019	BUY	$26.99 - $37.37 $383,932 - $531,588	14,225 Added 141.12%	24,305 $2.78 Million
Q3 2018 Nov 13, 2018	BUY	$23.35 - $36.72 $6,538 - $10,281	280 Added 2.86%	10,080 $1.44 Million
Q2 2018 Aug 10, 2018	SELL	$17.54 - $25.22 $16,277 - $23,404	-928 Reduced 8.65%	9,800 $931,000
Q4 2017 Feb 09, 2018	SELL	$11.12 - $15.38 $167,889 - $232,207	-15,098 Reduced 58.46%	10,728 $614,000
Q3 2017 Nov 09, 2017	BUY	$11.36 - $18.98 $293,383 - $490,177	25,826	25,826 $1.17 Million

Others Institutions Holding DXCM

# of Institutions

1,013

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Dexcom Inc Transaction History